VolitionRx (NYSEAMERICAN:VNRX) Shares Cross Above 50-Day Moving Average – Here’s Why

VolitionRx Limited (NYSEAMERICAN:VNRX) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.61. VolitionRx shares last traded at $0.56, with a volume of 291,323 shares.

VolitionRx Stock Down 7.7 %

The stock has a market cap of $35.38 million, a P/E ratio of -1.00 and a beta of 1.59.

VolitionRx (NYSEAMERICAN:VNRX) last announced its earnings results on Wednesday, August 14th. The medical research company reported ($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.01. VolitionRx had a negative net margin of 9,158.31% and a negative return on equity of 15,493.47%. The company had revenue of $0.40 million during the quarter, compared to analysts’ expectations of $0.34 million. On average, equities research analysts predict that VolitionRx Limited will post -0.5 earnings per share for the current fiscal year.

VolitionRx Company Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.